Nuvalent (NUVL) EPS (Weighted Average and Diluted) (2020 - 2026)

Nuvalent filings provide 7 years of EPS (Weighted Average and Diluted) readings, the most recent being -$1.39 for Q1 2026.

  • Quarterly EPS (Weighted Average and Diluted) fell 17.8% to -$1.39 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$6.06 through Mar 2026, down 37.73% year-over-year, with the annual reading at -$5.85 for FY2025, 48.85% down from the prior year.
  • EPS (Weighted Average and Diluted) hit -$1.39 in Q1 2026 for Nuvalent, up from -$1.58 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.36 in Q1 2022 and bottomed at -$1.7 in Q3 2025.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.88, with a median of -$0.69 recorded in 2024.
  • Peak annual rise in EPS (Weighted Average and Diluted) hit 88.01% in 2022, while the deepest fall reached 484.62% in 2022.
  • Nuvalent's EPS (Weighted Average and Diluted) stood at -$0.5 in 2022, then fell by 24.0% to -$0.62 in 2023, then plummeted by 70.97% to -$1.06 in 2024, then crashed by 49.06% to -$1.58 in 2025, then increased by 12.03% to -$1.39 in 2026.
  • Per Business Quant, the three most recent readings for NUVL's EPS (Weighted Average and Diluted) are -$1.39 (Q1 2026), -$1.58 (Q4 2025), and -$1.7 (Q3 2025).